Multi-Cancer Early Screening
Most cancer screening methods focus on one organ at a time. Multi-Cancer early screening offers a different approach, screening for up to 50 or more different types of cancer in a simple blood draw.
Also known as Multi-Cancer Early Detection (MCED), this approach harnesses the power of genomics to detect cancer at its earliest stages. This non-invasive blood test identifies cancer biomarkers in the blood, enabling timely intervention and treatment, improving outcomes.
A seamless, personalised experience, guided by your doctor — a white-glove approach from screening to review.
Multi-Cancer Early Screening At A Glance
Up to 50 Cancers Screened
Detects early signals of up to 50 cancers in the early stage, when treatment is most effective.
Non-Invasive
No surgery, no biopsy, no downtime. A simple blood test, no fasting required.
Comprehensive Insights
Early detection for multiple cancers in a single test before symptoms appear.
Proven Accuracy
81% sensitivity and 99% specificity*, improved accuracy over traditional tumour markers.
*Applies to LucenceINSIGHT™ tests
Recommended Profiles
For adults above 40, heavy smoking or drinking, family history of cancer or liver diseases such as Hepatitis B or C.
Doctor-led Review
Cancer screening test results are reviewed by experienced medical professionals to provide tailored recommendations.
The White-Glove Experience
Dedicated Concierge Support
Effortlessly access information and schedule your teleconsultation—all through the convenience of WhatsApp.
Doctor Consult
Understand the test pre- screening and discuss your results with our doctor at your convenience via teleconsultation.
Homebased Service
Complete your screening in comfort and privacy of your home, without any disruption to your schedule.
Multi-Cancer Early Screening Tests
Options vary primarily by the breadth of cancer coverage
6 Cancers Screen
LucenceINSIGHT™ Core
$689
(incl. gst)
6 Cancer Types
Lung (Small cell lung cancer, Non-small cell lung cancer)
Colorectal
Breast
Liver
Pancreatic
Thyroid
10 Cancers Screen
SPOT-MAS™
$789
(incl. gst)
10 Cancer Types
Breast
Lung
Colorectum
Stomach
Head & Neck
Endometrium
Pancreas
Esophagus
Ovary
Liver–Biliary Tract
12 Cancers Screen
LucenceINSIGHT™ 12
$1,929
(incl. gst)
12 Cancer Types
Lung (Small cell lung cancer, Non-small cell lung cancer)
Colorectal
Liver
Pancreatic
Thyroid
Stomach
Gastrointestinal stromal tumor (GIST)
Nasopharyngeal
Endometrial
For Men
Bladder
Prostate
Kidney
For Women
Breast
Ovarian
Cervical
50 Cancers Screen
LucenceINSIGHT™ 50
$3,799
(incl. gst)
50 Cancer Types
Lung (Small cell lung cancer, Non-small cell lung cancer)
Colorectal
Liver
Pancreatic
Thyroid
Breast
Ovarian
Bladder
Prostate
Kidney (Clear cell)
Esophageal
Stomach
Gastrointestinal stromal tumor (GIST)
Cervical
Endometrial
Stomach Neuroendocrine Tumors
Colorectal Neuroendocrine Tumors
Ovarian Germ cell & Stromal Tumors
Lung Neuroendocrine Tumors
Myeloproliferative Neoplasm
Acute Myeloid Leukemia
Non-Hodgkin Lymphoma
Hairy Cell Leukemia
Adult Wilms Tumor
Mast Cell Tumor
Small Intestine
Adrenal Gland
Biliary Tract
Soft Tissue
Myeloma
Testicular
Bone
Skin
Eye
Head
Neck
Vulvar
Penile
Register Your Interest
Our Customer Care team will be in touch within 3 working days to schedule a doctor consultation. You can learn more about the test and decide if it is right for you.
Frequently Asked Questions
If you would like to learn more about multi-cancer early screening before booking, view our multi-cancer early screening FAQ and educational guide.
Multi-Cancer Early Screening/ Multi-Cancer Early Detection (MCED)
Multi-Cancer Early Screening or Multi-Cancer Early Detection (MCED) refers to blood-based tests that screen for signals associated with multiple cancer types. These tests aim to identify potential cancer risk earlier, before symptoms appear.
No. Multi-Cancer Early Detection (MCED) is a screening tool and does not diagnose cancer. If a signal is detected, further medical evaluation may be required.
No. Multi-Cancer Early Screening complements recommended national screening programmes such as mammograms, Pap smears, or colon screening. It does not replace them.
Multi-Cancer Early Screening or Multi-Cancer Early Detection (MCED) tests differ mainly by:
- – The number of cancer types screened
- – The technology used to detect cancer-related signals
Multi-Cancer Early Screening or Multi-Cancer Early Detection (MCED) may be considered by individuals who:
- – Want additional screening beyond routine tests
- – Have concerns about cancer risk
- – Prefer a broader assessment of potential cancer signals
- – Well individuals aged 40 and above without personal history of cancer
- – Individuals with elevated risk for cancer (eg, family history of cancer, diet, lifestyle etc)
Suitability should be discussed with a doctor.
People who are newly diagnosed with cancer and ongoing active treatment for cancer, or who just finished treatment within 3 years, should avoid Multi-Cancer Early Screening or Multi-Cancer Early Detection (MCED). A doctor will check your medical history to make sure it is suitable for you to proceed.
Multi-Cancer Early Detection (MCED) test report ready within 12 to 18 working days, with a detailed post-review consultation with our doctors.
It is typically recommended to have screenings annually. Regular annual screenings play a vital role in detecting cancer at its earliest stages when treatment is often most effective. These screenings allow us to monitor any changes in your health and detect potential signs of cancer early on. We will determine the most suitable screening frequency based on your individual risk factors and medical history. Discuss with a doctor to understand more.